[1]
Castillo Velarde, E., Delgado Cabrera, D., Tinoco Begazo, M.A. and Alarcón-Ruiz, C. 2020. The use of ACE inhibitors and ARA II does not reduce the progression of chronic kidney disease stage 3-4 in diabetic nephropathy. Revista de Nefrología, Diálisis y Trasplante. 40, 2 (Sep. 2020), 185-188.